Skip to content

Legorreta Pablo G.

Reporting owner on Forms 3, 4 and 5, CIK 1507678.

Legorreta Pablo G. reported on 1 issuer in 25 filings, the latest a Form 4 filed 2026-11-06.

Issuers

IssuerRoles in the latest filingFilingsLast filed
RPRX · Royalty Pharma plcCIK 1802768director, officer (CEO, Chairman of the Board)12026-11-06

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-04A granted+42,209$01,350,029Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 1,040,410Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 901,590Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 600,000Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 460,139Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 292,190Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 123,310Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 118,500Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 41,306Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 10,000Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 10,000Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 6,930Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001507678-26-000008 Royalty Pharma plc2026-11-06
13F-NT 0000950123-25-007102 Quarter ended 2025-06-302025-08-06acceptance time not in the bulk data set
13F-NT 0001507678-25-000007 Quarter ended 2025-03-312025-05-02acceptance time not in the bulk data set
13F-NT 0001507678-25-000003 Quarter ended 2024-12-312025-02-03acceptance time not in the bulk data set
13F-NT 0001507678-24-000012 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-NT 0001507678-24-000009 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-NT 0001507678-24-000005 Quarter ended 2024-03-312024-05-08acceptance time not in the bulk data set
13F-NT 0001507678-24-000002 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-NT 0001507678-23-000044 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-NT 0001507678-23-000040 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-NT 0001507678-23-000022 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-NT 0000950123-23-002715 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-NT 0001507678-22-000014 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-NT 0001507678-22-000011 Quarter ended 2022-06-302022-08-10acceptance time not in the bulk data set
13F-NT 0001507678-22-000008 Quarter ended 2022-03-312022-05-11acceptance time not in the bulk data set
13F-NT 0001507678-22-000003 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-NT 0001507678-21-000016 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-NT 0001507678-21-000013 Quarter ended 2021-06-302021-08-12acceptance time not in the bulk data set
13F-NT 0001507678-21-000010 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-NT 0001507678-21-000006 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-NT 0001507678-20-000014 Quarter ended 2020-09-302020-11-12acceptance time not in the bulk data set
13F-NT 0001507678-20-000009 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-NT 0001507678-20-000006 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-NT 0001507678-20-000003 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-NT 0001507678-19-000009 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set